Infiltration of immune cells in the subcutaneous and visceral adipose tissue (AT) deposits leads to a low-grade inflammation contributing to the development of obesity-associated complications such as type 2 diabetes. To quantitatively and qualitatively investigate the immune cell subsets in human AT deposits, we have developed a flow cytometry approach. The stromal vascular fraction (SVF), containing the immune cells, is isolated from subcutaneous and visceral AT biopsies by collagenase digestion. Adipocytes are removed after centrifugation. The SVF cells are stained for multiple membrane-bound markers selected to differentiate between immune cell subsets and analyzed using flow cytometry. As a result of this approach, pro-and anti-inflammatory macrophage subsets, dendritic cells (DCs), B-cells, CD4
Introduction
Obesity is characterized with low-grade AT inflammation 1 and infiltration of pro-inflammatory immune cells in both visceral and subcutaneous AT (vAT, sAT). Accumulation of pro-inflammatory immune cells in the vAT leads to insulin resistance which is a primary risk factor for developing type 2 diabetes 2 . Immune cells of both the innate and adaptive immune system are found in the obese AT, such as macrophages, mast cells, neutrophils, CD4 + and CD8 + T-cells, and B-cells 3, 4, 5, 6, 7 . These immune cells, together with endothelial cells, stromal cells, adipocyte progenitors, fibroblasts, and pericytes, constitute the SVF 8 and are the main source of pro-inflammatory substances in the AT 9 .
The inflammatory status of AT is commonly investigated by techniques including Western blot 10 , qPCR 11 , and immunohistochemistry 11 . However, when using these techniques, the entire AT, adipocytes, and SVF, is used. This makes it difficult to determine the amount and subsets of immune cells present in the AT. Immune cells have various cell markers to define and categorize them, such as macrophages. Macrophages show significant heterogeneity in both function and cell surface marker expression 12 . Therefore, they are often categorized into two macrophage populations: M1 and M2. M2 macrophages are usually called alternatively activated macrophages 12, 13 and reside in the AT of lean, metabolically normal humans 14 . However, during obesity, a phenotypic switch occurs from M2 macrophages to M1 macrophages. These classically activated M1 macrophages express CD11C 12 and accumulate around dead adipocytes to form crown-like structures 13 . It has been shown that CD11C + macrophages in the AT impair insulin action and are associated with insulin resistance in obese humans 15 . To identify M1 and M2 macrophages in the AT, immunohistochemistry is an option. This technique gives information about the location of the macrophages in the tissue. However, it will limit the number of markers that can be used in one staining. Moreover, it is also difficult to quantify. Therefore, to investigate the different immune cell subsets in the vAT and sAT deposits, we have developed a flow cytometry approach. This approach gives us the opportunity to use multiple markers per cell with one flow cytometry analysis to define cell subsets and count the numbers of each subset present in the AT deposits.
1. Dissolve the cell pellet in 90 µL 4 °C FACS buffer and add 10 µL of 1 mg/mL human IgG block. Divide the cell suspension in 2 wells of a 96 vshape well plate. Place the plate on ice and let the human IgG block incubate for 15 min. 2. Add 100 µL FACS buffer to each sample to wash and centrifuge the plate for 5 min with 280 x g at 4 °C. Remove the supernatant by tipping the plate upside down in one smooth movement without tapping the plate. NOTE: Make sure to remove any remaining liquid from the top of the plate with a tissue while keeping the plate upside down. 3. Prepare antibody cocktails for macrophage and DC subsets (FACS panel 1) and for T-and B-cell subsets (FACS panel 2) as described in Table 1 and Table 2 . The volumes described in Table 1 and NOTE: A minimum of 50,000 events in the live gate is recommended to ensure enough cells are measured from each subpopulation.
Representative Results
The SVF isolated from vAT and sAT was measured using flow cytometry. Figure 1D ). The number of cells in each gate is quantified and can be used to calculate the percentage of this cell type of all living cells ( Table 3 ).
The percentage of living cells can be calculated for each subject allowing the calculation of an average of all subjects in a group of for example lean or obese men displaying the abundance of a specific immune cell, i.e., the pro-inflammatory CD11b + CD11c + macrophage in visceral AT (Figure 2) . An identical gating strategy is used for subcutaneous adipose tissue. An identical gating strategy is used for subcutaneous adipose tissue. This figure has been modified from Wouters et al. 16 Please click here to view a larger version of this figure. Flow cytometry of tissue immune cells is a powerful technique to phenotype the immunological state of tissues. The quantification of tissue immune cells can have many applications. As described in the results, it is possible to compare the presence of specific immune cells between groups of patients (e.g., lean vs. obese). In addition, by also performing flow cytometry on blood of the same patients, associations between circulating cells and tissue cells can be investigated. With this application we were able to determine that a specific subset of circulating monocytes is associated with pro-inflammatory CD11C + adipose tissue macrophages 16 .
Adjustments to the described protocol will expand its applications as numerous available fluorescent antibodies make flow cytometry very versatile. With different antibodies nearly all cell types can be distinguished and the expression of many markers can be detected. Furthermore, it is possible to stain markers intracellularly by permeabilizing the cell membrane to allow intracellular binding of the fluorescent antibodies. These characteristics allow distinction of the very diverse macrophage populations beyond the overly simplified M1 and M2 macrophage subtypes. Besides measurement of surface marker expression, proteins (i.e., cytokines) can be stained intracellularly providing information on macrophage functionality. In addition, proliferation markers such as Ki67 are used to quantify proliferation rates. As described, distinction between macrophages and DCs was based on MFI levels of DC markers. A general macrophage marker, such as CD68 can be incorporated into the macrophage panel (FACS panel 1). However, CD68 needs to be stained intracellularly requiring permeabilization of the cell membrane which is not preferable and would extend the protocol. Other macrophage markers are subset markers such as CD163 and CD206 or CD11c, the latter being integrated in the macrophage panel presented here.
In our FACS panels, a marker to distinguish live and dead cells was not included, which would be preferable because it allows a more accurate exclusion of dead cells than the use of FSC and SSC. Frequently used are the DNA staining viability dyes propidium iodide (PI) or 4',6-diamidino-2-phenylindole (DAPI) as well as free amine reacting dyes such as the LIVE/DEAD Fixable Dead Cell Stain Kit, which is available in different dye colors. However, PI and DAPI cannot be used when fixing the cells. As described in the protocol, the LIVE/DEAD Fixable Red Dead Cell viability staining can be integrated into both panels without affecting the overall FACS gating strategy.
In addition, the data are expressed as a percentage of live cells meaning all data are relative. Only by entering an exact, known number of cells into the flow cytometer, would it be possible to determine the exact numbers of each cell type. An approximate number of cells could be calculated after counting the cells in the SVF fraction by using a counting chamber. However, this number would have to be adjusted for the amount of biopsy tissue used to isolate the SVF, but this has limitations when comparing lean to obese AT. A similar mass of obese AT consists of less adipocytes as they are filled with lipids and have expanded greatly. This could lead to an underestimation of immune cell number if presented as number of immune cells per gram of AT or per adipocyte.
In human studies, inclusion of patients is usually done over a longer period of time making standardization of experimental procedures of great importance. For comparison of flow cytometry data between patients, there are several options. As described in this protocol, cells can be fixed before measurement allowing analysis of several samples on the same day. This can also be achieved by freezing the SVF before staining them, which allows the staining procedure to be equal between all samples, but the viability of cells might be affected. Lastly, also employed in this study, are fluorescent beads to install compensation levels, and cytometer tracking beads were used bi-weekly to standardize daily measurements of the cytometer. This last option is the most efficient when measuring samples from a study spanning a long period of time.
A limiting factor for flow cytometry in general is the use of fluorescence. The number of fluorescent labels that can be detected simultaneously is limited due to overlap in emission spectra. However, with smart FACS panel development and the use of several antibody cocktails per vAT or sAT sample, this issue can be overcome as described in this protocol. An important aspect of FACS panel development is FMO controls. By using all antibodies of the panel except for one, potential autofluorescence levels can be appreciated when comparing the FMO with the full panel. This allows accurate gating of populations and these procedures should be performed when setting up a new FACS panel. In addition, new generations of FACS devices can detect up to 50 parameters allowing simultaneous detection of many characteristics per cell. Another issue related to the fluorescence aspect is the autofluorescence of cells, particularly macrophages. After excitation of the cells with the FACS laser (mainly with 488 nm wavelength excitation), these cells emit a fluorescent signal (mainly <640 nm) that can overlap with the emission spectra of the antibody labels 17, 18 . To account for this, unstained cells should be measured to determine the autofluorescence in each channel. With this knowledge, fluorochromes should be selected that display a signal strength that exceeds the autofluorescent signal. This autofluorescent background signal should be taken into account when determining the gating strategy of the populations. Therefore, by application of this protocol and intelligent FACS panel design it is possible to in depth phenotype macrophage subtypes. New distinct AT macrophages and their function can be characterized.
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